Disposition of 114 shares by Cindy Ferguson of ATRION at 617.1 subject to Rule 16b-3
Under 67% of ATRION's investor base is looking to short. The analysis of current outlook of investing in ATRION suggests that many traders are alarmed regarding ATRION's prospects. ATRION's investing sentiment shows overall attitude of investors towards ATRION.
ATRION |
Filed transaction by ATRION Officer Officer Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
ATRION Fundamental Analysis
We analyze ATRION's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRION using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRION based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
ATRION is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
ATRION Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ATRION stock to make a market-neutral strategy. Peer analysis of ATRION could also be used in its relative valuation, which is a method of valuing ATRION by comparing valuation metrics with similar companies.
Peers
ATRION Related Equities
COO | Cooper Companies, | 0.28 | ||||
MMSI | Merit Medical | 0.01 | ||||
ATR | AptarGroup | 0.21 | ||||
AKYA | Akoya Biosciences | 0.45 | ||||
KRMD | Repro Med | 0.50 | ||||
ANGO | AngioDynamics | 0.56 | ||||
NVST | Envista Holdings | 1.39 | ||||
HAE | Haemonetics | 2.54 | ||||
ATRC | AtriCure | 2.54 | ||||
ICUI | ICU Medical | 2.68 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in ATRION Stock
If you are still planning to invest in ATRION check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATRION's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |